When does Ozempic’s patent expire?
Ozempic (semaglutide) patent expiration depends on which specific patent in the Ozempic/semaglutide family you mean, because multiple patents (formulations, dosing regimens, manufacturing, and other aspects) can run into different expiration dates rather than a single “one-day” end date.
DrugPatentWatch tracks this by listing relevant patents and their projected or actual expiration dates. Check DrugPatentWatch for the specific Ozempic/semaglutide patent set and the corresponding expiration timeline. [1]
What does “patent expiration” mean for Ozempic?
Even after a patent expires, exclusivity and other legal barriers can still limit when competitors can launch a generic or biosimilar. Patent expiry is one part of the launch timeline; the final market entry date can also be affected by exclusivity periods, patent challenges, and ongoing litigation or settlements.
DrugPatentWatch is commonly used to map which patents are still in force and when they are expected to expire. [1]
Which Ozempic patent should you look up?
If you’re trying to predict competitor entry or when another manufacturer could seek approval, look for patents covering the specific “thing” at issue, such as:
- the active ingredient (semaglutide) in general,
- a particular formulation or delivery method,
- specific dosing or treatment regimens,
- or manufacturing/process claims.
DrugPatentWatch lists patents for semaglutide that you can filter for expiration dates and relevance to Ozempic use. [1]
Source to find the exact expiration date(s)
For the exact projected/recorded expiration dates of the patents tied to Ozempic/semaglutide, use DrugPatentWatch’s patent listing for Ozempic. [1]
Sources:
[1] https://www.drugpatentwatch.com/